0001667699-19-000001.txt : 20190923 0001667699-19-000001.hdr.sgml : 20190923 20190923170535 ACCESSION NUMBER: 0001667699-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190923 DATE AS OF CHANGE: 20190923 EFFECTIVENESS DATE: 20190923 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Renibus Therapeutics, Inc. CENTRAL INDEX KEY: 0001667699 IRS NUMBER: 810872431 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-349442 FILM NUMBER: 191108620 BUSINESS ADDRESS: STREET 1: 950 E. STATE HIGHWAY 114 STREET 2: STE-160 CITY: SOUTHLAKE STATE: TX ZIP: 76092 BUSINESS PHONE: 386-527-1071 MAIL ADDRESS: STREET 1: 950 E. STATE HIGHWAY 114 STREET 2: STE-160 CITY: SOUTHLAKE STATE: TX ZIP: 76092 D 1 primary_doc.xml X0708 D LIVE 0001667699 Renibus Therapeutics, Inc. 950 E. State Highway 114 Suite 160 Southlake TX TEXAS 76092 817.722.5768 DELAWARE None None Corporation true 2015 Alvaro Guillem 950 E. State Highway 114 Suite 160 Southlake TX TEXAS 76092 Executive Officer Director Chairman of the Board, Chief Executive Officer D. Jeffrey Keyser 950 E. State Highway 114 Suite 160 Southlake TX TEXAS 76092 Executive Officer Director President, Secretary and Chief Operating Officer Henrik Rasmussen 950 E. State Highway 114 Suite 160 Southlake TX TEXAS 76092 Director Bhupinder Singh 950 E. Highway 114 Suite 160 Southlake TX TEXAS 76092 Director Pharmaceuticals Decline to Disclose 06b false 2019-09-12 false true false 0 3374008 3374008 0 false 8 0 0 0 false Renibus Therapeutics, Inc. /s/ Alvaro Guillem Alvaro Guillem Chairman of the Board and CEO 2019-09-23